A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Inclusion Criteria:
Exclusion Criteria:
Charleston, South Carolina 29425, United States
Aachen, 52074, Germany
Roma, 00189, Italy
Ankara, 06100, Turkey (Türkiye)
Ankara, 06490, Turkey (Türkiye)
Ankara, 06530, Turkey (Türkiye)
Bursa, 16059, Turkey (Türkiye)
Istanbul, 34093, Turkey (Türkiye)
Izmir, 35100, Turkey (Türkiye)
Izmir, 35340, Turkey (Türkiye)
Leicester, LE15WW, United Kingdom